Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
3-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.4
advertisement
11.4 Prostaglandins
(22)
Showing records 1 to 22
Display all abstracts in classification
11.4 Prostaglandins
Search within classification 11.4 Prostaglandins
19118
An evaluation of the effect of unoprostone isopropyl 0.15% on ocular hemodynamics in normal-tension glaucoma patients
Beano F; Orgül S; Stümpfig D; Gugleta K; Flammer J
Graefe's Archive for Clinical and Experimental Ophthalmology
2001; 239: 81-86
19119
Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management
Cantor LB
Expert Opinion on Investigational Drugs
2001; 10: 721-731
19120
Misoprostol therapeutics revisited
Davies NM; Longstreth J; Jamali F
Pharmacotherapy
2001; 21: 60-73
19121
Ischemia increases prostaglandin H synthase-2 levels in retina and visual cortex in piglets
Degi R; Thore C; Bari F; Thrikawala N; Nogradi A; Robins G; Domoki F; Beasley TC; Busija DW
Graefe's Archive for Clinical and Experimental Ophthalmology
2001; 239: 59-65
19122
Latanoprost-associated recurrent herpes simplex keratitis
Dios Castro E; Maquet Dusart JA
Archivos de la Sociedad Española de Oftalmologia
2000; 75: 775-778
19123
Latanoprost exerts neuroprotective activity in vitro and in vivo
Drago F; Valzelli S; Emmi I; Marino A; Scalia CC; Marino V
Experimental Eye Research
2001; 72: 479-486
19124
Latanoprost and the ibopamine test: a year's experience
Giraldi JP; Mollicone A; Seguto D; Simeone L; Zaccara F
Acta Ophthalmologica Scandinavica, Supplement
2000; 78: 70-71
19125
The iris after prostanoid treatment
Grierson I; Cracknell KP; Pfeiffer N
Current Opinions in Ophthalmology
2001; 12: 112-118
19126
Effects of latanoprost instillation on the accommodation and pupil size in normal young adults
Katsumura K; Utsumi T; Watanabe T; Oku H; Sugasawa J; Nakajima M
Japanese Journal of Clinical Ophthalmology
2001; 55: 221-225
19127
Therapeutic potential of prostaglandin analogues in glaucoma
Linden C
Expert Opinion on Investigational Drugs
2001; 10: 679-694
19128
Short-time application of latanoprost does not stimulate melanogenesis in bovine ocular melanin-containing cells in vitro
Loeffler KU; Sahm M; Spitznas M
Ophthalmic Research
2001; 33: 102-106
19129
Additive ocular hypotensive effect of latanoprost 0.005% on previous beta antagonist-using patients
Machado Fontes ML; Ribeiro AL; Castor C; Yamane R
Revista Brasileira de Oftalmologia
2000; 59: 711-717
19130
The effect of 0.12% unoprostone isopropyl (rescula) on intraocular pressure in normotensive dogs
Ofri R; Raz D; Kass PH; Lambrou GN; Percicot CL
Journal of Veterinary Medical Science
2000; 62 1313-1315
19131
Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study
Pfeiffer N; Grierson I; Goldsmith H; Hochgesand D; Winkgen-Boehres A; Appleton P
Archives of Ophthalmology
2001; 119: 191-196
19132
Ocular complications of latanoprost in uveitic glaucoma: three case reports
Sacca SC; Pascotto A; Siniscalchi C; Rolando M
Journal of Ocular Pharmacology and Therapeutics
2001; 17: 107-113
19133
Additive efficacy of unoprostone isopropyl 0.12% (Rescula) to latanoprost 0.005%
Stewart WC; Sharpe ED; Stewart JA; Holmes KT; Latham KE
American Journal of Ophthalmology
2001; 131: 339-344
19134
A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension
Susanna R Jr; Giampani J Jr; Borges AS; Vessani RM; Jordao MLS
Ophthalmology
2001; 108: 259-263
19135
The pros and cons of different prostanoids in the medical management of glaucoma
Susanna R Jr; Medeiros FA
Current Opinions in Ophthalmology
2001; 12: 149-156
19136
Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma
Tamada Y; Taniguchi T; Murase H; Yamamoto T; Kitazawa Y
Journal of Ocular Pharmacology and Therapeutics
2001; 17: 19-25
19137
Latanoprost and periocular skin color changes
Wand M; Ritch R; Isbey EK; Zimmerman TJ
Archives of Ophthalmology
2001; 119: 614-615
19138
Migraine headache associated with latanoprost
Weston BC
Archives of Ophthalmology
2001; 119: 300-301
19139
Latanoprost-induced side effects and potential mechanisms
Zhai X; Samples JR
Journal of Toxicology – Cutaneous and Ocular Toxiclogy
2000; 19: 177-197
Issue
3-1
Table of Contents
Editor's Selection
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement